Published in Cell Mol Neurobiol on January 19, 2007
Evidence for oxidative stress in tissues derived from succinate semialdehyde dehydrogenase-deficient mice. J Inherit Metab Dis (2007) 1.06
Disruption of mitochondrial homeostasis in organic acidurias: insights from human and animal studies. J Bioenerg Biomembr (2011) 0.98
Increased glutamate receptor and transporter expression in the cerebral cortex and striatum of gcdh-/- mice: possible implications for the neuropathology of glutaric acidemia type I. PLoS One (2014) 0.85
Neonatal astrocyte damage is sufficient to trigger progressive striatal degeneration in a rat model of glutaric acidemia-I. PLoS One (2011) 0.83
Glutaric acid-mediated apoptosis in primary striatal neurons. Biomed Res Int (2014) 0.79
Neurotoxic effects of trans-glutaconic acid in rats. Oxid Med Cell Longev (2013) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Catalase in vitro. Methods Enzymol (1984) 27.79
The L-arginine-nitric oxide pathway. N Engl J Med (1993) 14.38
Hydroperoxide metabolism in mammalian organs. Physiol Rev (1979) 14.13
A diet-induced mouse model for glutaric aciduria type I. Brain (2006) 2.31
Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res (2006) 2.31
Glutathione peroxidase. Methods Enzymol (1981) 2.07
Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort. Brain (2005) 1.84
The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J Inherit Metab Dis (2004) 1.75
Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet C Semin Med Genet (2003) 1.69
Glutaric aciduria type I: clinical heterogeneity and neuroradiologic features. Neurology (1987) 1.69
Regulation of antioxidant enzymes. FASEB J (1992) 1.48
Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle. Free Radic Biol Med (1991) 1.28
CT and MR of the brain in glutaric acidemia type I: a review of 59 published cases and a report of 5 new patients. AJNR Am J Neuroradiol (1995) 1.24
Mutation analysis in glutaric aciduria type I. J Med Genet (2000) 1.23
Glutaric aciduria: biochemical and morphologic considerations. J Pediatr (1977) 1.23
An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration. Brain Res Brain Res Rev (1999) 1.17
Correlation of genotype and phenotype in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis (2004) 1.14
Glutaric aciduria type I: pathomechanisms of neurodegeneration. J Inherit Metab Dis (1999) 1.14
Plasma antioxidants and longevity: a study on healthy centenarians. Free Radic Biol Med (2000) 1.11
Simple procedure for specific assay of lipid hydroperoxides in serum or plasma. Methods Mol Biol (1998) 1.10
Biochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type I. Hum Mol Genet (2002) 1.08
Neurogenesis and brain injury: managing a renewable resource for repair. J Clin Invest (2003) 1.08
Glutaric aciduria: inherited deficiency of glutaryl-CoA dehydrogenase activity. Biochem Med (1975) 1.05
Glutaric aciduria I: creatine supplementation restores creatinephosphate levels in mixed cortex cells from rat incubated with 3-hydroxyglutarate. Mol Genet Metab (2003) 1.03
Glutaric aciduria type I: from clinical, biochemical and molecular diversity to successful therapy. J Inherit Metab Dis (1999) 1.02
Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. Arch Biochem Biophys (2001) 1.00
Enalapril and captopril enhance glutathione-dependent antioxidant defenses in mouse tissues. Am J Physiol Regul Integr Comp Physiol (2000) 0.99
Pathomechanisms of neurodegeneration in glutaryl-CoA dehydrogenase deficiency. Ann Neurol (2004) 0.97
Reduced glutathione and glutathione disulfide. Methods Mol Biol (1998) 0.96
Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Radic Biol Med (1995) 0.95
Oxygen- or organic hydroperoxide-induced chemiluminescence of brain and liver homogenates. Biochem J (1981) 0.91
Ca(2+) and Na(+) dependence of 3-hydroxyglutarate-induced excitotoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatr Res (2002) 0.85
3-hydroxyglutaric acid enhances glutamate uptake into astrocytes from cerebral cortex of young rats. Neurochem Int (2004) 0.83
Glutaric acid induces oxidative stress in brain of young rats. Brain Res (2003) 0.82
Intrastriatal administration of 3-hydroxyglutaric acid induces convulsions and striatal lesions in rats. Brain Res (2001) 0.82
3-Hydroxyglutaric and glutaric acids are neurotoxic through NMDA receptors in vitro. J Inherit Metab Dis (1999) 0.81
Glutaric aciduria type I with high residual glutaryl-CoA dehydrogenase activity. Dev Med Child Neurol (1998) 0.81
Promotion of oxidative stress by 3-hydroxyglutaric acid in rat striatum. J Inherit Metab Dis (2005) 0.80
3-Hydroxyglutaric acid moderately impairs energy metabolism in brain of young rats. Neuroscience (2005) 0.80
Glutaric acid administration impairs energy metabolism in midbrain and skeletal muscle of young rats. Neurochem Res (2005) 0.80
3-Hydroxyglutaric acid induces oxidative stress and decreases the antioxidant defenses in cerebral cortex of young rats. Brain Res (2002) 0.80
Inhibition of energy production in vitro by glutaric acid in cerebral cortex of young rats. Metab Brain Dis (2000) 0.79
Contribution of reactive oxygen species to 3-hydroxyglutarate neurotoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatr Res (2001) 0.78
Glutaric acid stimulates glutamate binding and astrocytic uptake and inhibits vesicular glutamate uptake in forebrain from young rats. Neurochem Int (2004) 0.78
Evidence that 3-hydroxyglutaric acid interacts with NMDA receptors in synaptic plasma membranes from cerebral cortex of young rats. Neurochem Int (2004) 0.78
Chronic treatment with glutaric acid induces partial tolerance to excitotoxicity in neuronal cultures from chick embryo telencephalons. J Neurosci Res (2002) 0.78
Neuropathology in glutaric acidaemia type 1. Acta Neuropathol (1988) 0.77
Cerebral organic acid disorders induce neuronal damage via excitotoxic organic acids in vitro. Amino Acids (2000) 0.77
Age-dependent effects of t-BuOOH on glutathione disulfide reductase, glutathione peroxidase, and malondialdehyde in the brain. Mol Chem Neuropathol (1995) 0.76
Cerebral dicarboxylate transport and metabolism studied with isotopically labelled fumarate, malate and malonate. J Neurochem (2002) 0.76
Potentiation of 3-hydroxyglutarate neurotoxicity following induction of astrocytic iNOS in neonatal rat hippocampal cultures. Eur J Neurosci (2001) 0.75
Visible chemiluminescence from rat brain homogenates undergoing autoxidation. II. Kinetics of the luminescence decay. Free Radic Biol Med (1988) 0.75
Cellular aspects of liver regeneration. Acta Cir Bras (2006) 0.75
D-2-hydroxyglutaric acid induces oxidative stress in cerebral cortex of young rats. Eur J Neurosci (2003) 2.62
Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res (2006) 2.31
Antioxidant effect of cysteamine in brain cortex of young rats. Neurochem Res (2007) 1.59
Mitochondrial energy metabolism is markedly impaired by D-2-hydroxyglutaric acid in rat tissues. Mol Genet Metab (2005) 1.32
Induction of oxidative stress by L-2-hydroxyglutaric acid in rat brain. J Neurosci Res (2003) 1.25
An overview of L-2-hydroxyglutarate dehydrogenase gene (L2HGDH) variants: a genotype-phenotype study. Hum Mutat (2010) 1.11
Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease. Biochim Biophys Acta (2003) 1.11
L-2-Hydroxyglutaric aciduria: pattern of MR imaging abnormalities in 56 patients. Radiology (2009) 1.04
Resveratrol protects C6 astrocyte cell line against hydrogen peroxide-induced oxidative stress through heme oxygenase 1. PLoS One (2013) 1.02
Homocysteine induces oxidative stress, inflammatory infiltration, fibrosis and reduces glycogen/glycoprotein content in liver of rats. Int J Dev Neurosci (2009) 1.00
Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy. Biochim Biophys Acta (2011) 0.98
L-2-hydroxyglutaric acid inhibits mitochondrial creatine kinase activity from cerebellum of developing rats. Int J Dev Neurosci (2003) 0.96
Alpha-ketoisocaproic acid and leucine provoke mitochondrial bioenergetic dysfunction in rat brain. Brain Res (2010) 0.96
Hexacosanoic and docosanoic acids plasma levels in patients with cerebral childhood and asymptomatic X-linked adrenoleukodystrophy: Lorenzo's oil effect. Metab Brain Dis (2007) 0.93
In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain. Neurochem Int (2006) 0.93
L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders. Gene (2013) 0.92
Inhibition of brain energy metabolism by the branched-chain amino acids accumulating in maple syrup urine disease. Neurochem Res (2007) 0.91
alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defences in cerebral cortex from young rats. Metab Brain Dis (2005) 0.89
Gamma-hydroxybutyric acid induces oxidative stress in cerebral cortex of young rats. Neurochem Int (2006) 0.89
Medium-chain fatty acids accumulating in MCAD deficiency elicit lipid and protein oxidative damage and decrease non-enzymatic antioxidant defenses in rat brain. Neurochem Int (2009) 0.89
Early biochemical effects after unilateral hypoxia-ischemia in the immature rat brain. Int J Dev Neurosci (2011) 0.88
The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy. J Neurol Sci (2006) 0.87
Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain alpha-keto acids accumulating in maple syrup urine disease. Neurochem Int (2006) 0.87
L-carnitine blood levels and oxidative stress in treated phenylketonuric patients. Cell Mol Neurobiol (2008) 0.87
Inhibition of cytochrome c oxidase activity in rat cerebral cortex and human skeletal muscle by D-2-hydroxyglutaric acid in vitro. Biochim Biophys Acta (2002) 0.87
Marked reduction of Na(+), K(+)-ATPase and creatine kinase activities induced by acute lysine administration in glutaryl-CoA dehydrogenase deficient mice. Mol Genet Metab (2012) 0.87
Oxidative stress in phenylketonuria: what is the evidence? Cell Mol Neurobiol (2011) 0.86
Isovaleric acid reduces Na+, K+-ATPase activity in synaptic membranes from cerebral cortex of young rats. Cell Mol Neurobiol (2007) 0.86
Differential inhibitory effects of methylmalonic acid on respiratory chain complex activities in rat tissues. Int J Dev Neurosci (2006) 0.86
Effects of L-2-hydroxyglutaric acid on various parameters of the glutamatergic system in cerebral cortex of rats. Metab Brain Dis (2003) 0.86
Acute intrastriatal administration of quinolinic acid provokes hyperphosphorylation of cytoskeletal intermediate filament proteins in astrocytes and neurons of rats. Exp Neurol (2010) 0.86
Quinolinic acid reduces the antioxidant defenses in cerebral cortex of young rats. Int J Dev Neurosci (2005) 0.86
Chronic administration of branched-chain amino acids impairs spatial memory and increases brain-derived neurotrophic factor in a rat model. J Inherit Metab Dis (2012) 0.85
Induction of oxidative stress by the metabolites accumulating in isovaleric acidemia in brain cortex of young rats. Free Radic Res (2008) 0.85
In vivo and in vitro effects of proline on some parameters of oxidative stress in rat brain. Brain Res (2003) 0.85
Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease. Metab Brain Dis (2006) 0.85
Intracerebroventricular administration of N-acetylaspartic acid impairs antioxidant defenses and promotes protein oxidation in cerebral cortex of rats. Metab Brain Dis (2009) 0.85
Inhibition of the mitochondrial respiratory chain by phenylalanine in rat cerebral cortex. Neurochem Res (2002) 0.85
Effect of the branched-chain alpha-keto acids accumulating in maple syrup urine disease on S100B release from glial cells. J Neurol Sci (2007) 0.84
Guanosine enhances glutamate uptake in brain cortical slices at normal and excitotoxic conditions. Cell Mol Neurobiol (2002) 0.84
Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease. Int J Dev Neurosci (2003) 0.84
Long-chain 3-hydroxy fatty acids accumulating in LCHAD and MTP deficiencies induce oxidative stress in rat brain. Neurochem Int (2010) 0.84
Increased oxidative stress in patients with 3-hydroxy-3-methylglutaric aciduria. Mol Cell Biochem (2015) 0.84
Ascorbic acid prevents cognitive deficits caused by chronic administration of propionic acid to rats in the water maze. Pharmacol Biochem Behav (2002) 0.84
Maple syrup urine disease in treated patients: biochemical and oxidative stress profiles. Clin Biochem (2007) 0.84
Oxidative stress in patients with mucopolysaccharidosis type II before and during enzyme replacement therapy. Mol Genet Metab (2011) 0.84
In vitro effect of homocysteine on some parameters of oxidative stress in rat hippocampus. Metab Brain Dis (2003) 0.84
Neurodevelopmental and cognitive behavior of glutaryl-CoA dehydrogenase deficient knockout mice. Life Sci (2012) 0.83
Inhibition of the electron transport chain and creatine kinase activity by ethylmalonic acid in human skeletal muscle. Metab Brain Dis (2006) 0.83
Citrulline and ammonia accumulating in citrullinemia reduces antioxidant capacity of rat brain in vitro. Metab Brain Dis (2006) 0.83
Impairment of energy metabolism in hippocampus of rats subjected to chemically-induced hyperhomocysteinemia. Biochim Biophys Acta (2003) 0.83
Dual mechanism of brain damage induced in vivo by the major metabolites accumulating in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome. Brain Res (2010) 0.83
Experimental hyperphenylalaninemia provokes oxidative stress in rat brain. Biochim Biophys Acta (2002) 0.83
Guanidinoacetate decreases antioxidant defenses and total protein sulfhydryl content in striatum of rats. Neurochem Res (2008) 0.83
Effect of short- and long-term exposition to high phenylalanine blood levels on oxidative damage in phenylketonuric patients. Int J Dev Neurosci (2009) 0.83
DNA damage in leukocytes from pretreatment mucopolysaccharidosis type II patients; protective effect of enzyme replacement therapy. Mutat Res (2011) 0.83
Evidence for a synergistic action of glutaric and 3-hydroxyglutaric acids disturbing rat brain energy metabolism. Int J Dev Neurosci (2007) 0.83